mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
0.034 |
0.6 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.091 |
0.6 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.6 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.6 |